Omalizumab; 75 mg/0.5 mL injection, 1 x 0.5 mL syringe, 150 mg/mL injection, 1 x 1 mL syringe, 150 mg injection [1 x 150 mg vial] (&) inert substance diluent [1 x 1.2 mL ampoule], 1 pack; Xolair®

Page last updated: 6 March 2015

Public Summary Document (PSD) November 2014 PBAC Meeting - (PDF 415 KB)

Public Summary Document (PSD) November 2014 PBAC Meeting - (Word 204 KB)